List of works - Lisa M Rimsza

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

article

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

scientific article published in Nature

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

scientific article

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

scientific article

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

scientific article

Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

scientific article

Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues

scientific article

Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP

scientific article

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

scientific article

BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma

scientific article

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

scientific article

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

scientific article published on 12 August 2012

CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression

scientific article published on 19 February 2009

Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma

article

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

scientific article

Clinical laboratory validation of the MCL35 assay for molecular risk stratification of mantle cell lymphoma

scientific article published on 13 October 2020

Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma

scientific article published on February 2013

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

scientific article

Cooperative epigenetic modulation by cancer amplicon genes

scientific article

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

scientific article published on 25 August 2005

Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.

scientific article

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

scientific article published on 07 January 2014

Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

scientific article published on 5 October 2015

EZH2 mutations are frequent and represent an early event in follicular lymphoma

scientific article published on 19 September 2013

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

scientific article

Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms

scientific article published on 03 February 2014

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations

scientific article published on 26 May 2009

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

scientific article

Frequent occurrence of deletions in primary mediastinal B-cell lymphoma

article

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

scientific article published on 10 June 2008

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

scientific article

Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma

scientific article published on 26 November 2012

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

scientific article published on 19 February 2019

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

scientific article published in April 2018

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

scientific article published on 13 September 2013

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

scientific article

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

scientific article published on 10 December 2014

HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen

scientific article published on 01 March 2007

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.

scientific article

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

scientific article

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

scientific article published on 19 February 2004

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

scientific article published on 20 October 2005

Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma

scientific article

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

scientific article

MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype

scientific article published on 29 September 2011

Molecular diagnosis of Burkitt's lymphoma

scientific article published in June 2006

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

scientific article published on 28 February 2012

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

scientific article

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma

scientific article

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

scientific article published on 14 March 2017

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

scientific article

Oncogenically active MYD88 mutations in human lymphoma

scientific article

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

scientific article

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

article

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

scientific article

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

scientific article

Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma

scientific article

Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry

scientific article published on 01 December 2019

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.

scientific article

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

scientific article published on 17 June 2008

Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens

scientific article

Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma

scientific journal article

The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy

scientific article published on 06 August 2018

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

scientific article

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

scientific article

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

scientific article

Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

article

List of works by Lisa M Rimsza

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues

Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression

Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Clinical laboratory validation of the MCL35 assay for molecular risk stratification of mantle cell lymphoma

Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Cooperative epigenetic modulation by cancer amplicon genes

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

EZH2 mutations are frequent and represent an early event in follicular lymphoma

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Frequent occurrence of deletions in primary mediastinal B-cell lymphoma

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype

Molecular diagnosis of Burkitt's lymphoma

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

Oncogenically active MYD88 mutations in human lymphoma

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma

Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens

Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma

The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network